Explore Multiple Sclerosis, News Today and more!

Explore related topics

Brain-specific B Cells’ Reactivity Determines Glatiramer Acetate Therapy Success in MS Patients

Brain-specific B Cells' Reactivity Determines Glatiramer Acetate Therapy Success in MS Patients

Here, scientists discovered that MS patients response to glatiramer acetate therapy seems dependent of reactive brain-specific B cells in patients' blood.

MS : )  Just  think they said That nothing in Becky's head? lol

ᘻยℓէᎥƥℓҽ ᏕƈℓҽґσʂᎥʂ ( ͡° ͜ʖ ͡°) 【ツ ᘻᏕ Ӈยɱσґ 【ツ ¯_(ツ)_/¯ ~ Multiple Sclerosis - bright ideas I only have 44 great ideas.

11 Pictures of Multiple Sclerosis: How MS Affects Your Brain

Pictures of the Physiological Changes of MS

11 Pictures of Multiple Sclerosis: How MS Affects Your Brain . After watching panoramas programme there's a little light at end tunnel

Cryotechnology helping in the search for a cure

VistaGen Acquires 3 New Stem-cell Technologies from UHN of Canada - Huntington's Disease News

Life Hacks for people with multiple sclerosis! Great tips, tricks, and products designed to make life a little easier!

Life Hack for people with multiple sclerosis! Great tips, tricks, and products designed to make life a little easier!

Phase 1 Trial of Therapy for Autoimmune Diseases, Including Lupus, Initiated by…

Kezar Initiates Phase 1 Trial of Therapy for Autoimmune Diseases

Phase 1 Trial of Therapy for Autoimmune Diseases, Including Lupus, Initiated by Kezar

Potential Lupus Therapy, hCDR1, Granted a European Union Patent #LupusNewsToday

Potential Lupus Therapy, hCDR1, Granted a European Union Patent

Potential Lupus Therapy, Granted a European Union Patent

Aurinia to Detail Lupus Studies, Therapies in Aug. 4 Breakfast Meeting for Business Leaders

Aurinia Plans Aug. 4 Breakfast Detailing Lupus Studies, Therapies

Aurinia to Detail Lupus Studies, Therapies in Aug. 4 Breakfast Meeting for Business Leaders

ImmuPharma Extends Phase 3 Study of Lupus Therapy to Mauritius at Country’s…

Phase 3 Study of Lupus Therapy Opens in Mauritius at Country's Request

Read about ImmuPharma's Phase 3 study of Lupuzor (rigerimod), a potential lupus therapy, being extended to patients in Mauritius at the country's request.

Pinterest
Search